Lifespan: The Miriam Hospital
Providence, Rhode Island 02906
0 studies enrolling now · 32 studies all time
What they study most
Bladder Cancer, Breast Cancer, Childhood Germ Cell Tumor, Chronic Total Occlusion of Artery of the Extremities, Colorectal Cancer, Diarrhea, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Leukemia, Lung Cancer, Lymphoma
Studies at this site
- Treatment of Calcific Total Occlusions in Peripheral Artery Disease — Status unconfirmed
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
- Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
- Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
- Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer — Completed
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver — Completed
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer — Completed
- Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma — Completed
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
- Docetaxel in Treating Patients With Solid Tumors — Completed
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Completed
- Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
- Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas — Completed
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer — Completed
- Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer — Completed
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma — Completed
- Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy — Completed
- Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
- Irinotecan in Treating Aging Patients With Solid Tumors — Completed
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — Completed
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
- S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis — Completed
- Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
- Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer — Completed
- Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors — Completed
- Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer — Completed
- S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery — Stopped early
- Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 — Completed
- Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed